主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ARTL
#9739
Artelo Biosciences, Inc. Common Stock
3.760
0
USD
-3.59%
版块:
医疗保健
基础:
USD
利润货币:
USD
日范围
年范围
日变化
-3.59%
每月变动
+213.33%
6个月变化
+213.33%
年变化
+213.33%
前一天收盘价
3.900
0
Open
3.760
0
Bid
3.760
0
Ask
3.763
0
Low
3.760
0
High
3.760
0
交易量
1
市场
股票
医疗保健
ARTL
Open full chart
Financials
Overview
声明
Statistics
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
537.95 K
546.84 K
546.84 K
1.32 M
2.02 M
2.12 M
—
Valuation ratios
Enterprise value
—
—
—
17.29 M
7.3 M
1.99 M
—
Price to earnings ratio
—
—
—
-0.7
-0.22
-0.1
—
Price to sales ratio
—
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
1.32
0.35
0.15
—
Price to book ratio
—
—
—
0.64
0.47
0.99
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.16
0.8
0.67
0.74
0.73
1.49
3.63
Return on equity %
0.18
1.32
3.64
2.29
4.93
3.28
14.13
Return on invested capital %
115.86
357.6
366.21
464.69
384.5
340.43
1 555.83
Gross margin %
—
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
7.15
1.44
0.49
0.39
0.38
0.17
1.43
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
0.18
0.21
0.16
—
Long term debt to total equity ratio
—
—
—
0.56
1.38
0.34
—
Per share metrics
Operating cash flow per share
1.45
4.78
2.92
0.9
4.44
2.83
11.09
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
1.39
0.47
1.74
0.44
2.5
0.58
5.26
Net current asset value per share
9.27
4.76
2.53
3.89
2.32
0.68
9.41
Tangible book value per share
8.03
1.52
-2.54
-1.1
-1.79
-0.75
-6.17
Working capital per share
7.97
1.46
-2.6
-6.06
-3.85
-3.25
-15.77
Book value per share
11.82
5.32
1.19
2.45
0.8
1.24
5.68
新闻
Artelo Biosciences实施1比3反向拆股
Artelo Biosciences implements 3-for-1 reverse stock split
Artelo Biosciences报告2025年亏损1290万美元
Artelo Biosciences reports $12.9M loss for 2025
Artelo Biosciences因缺乏法定人数休会年度股东大会
Artelo Biosciences adjourns annual meeting due to lack of quorum
White House launches Medicare pilot program for CBD reimbursement
Artelo的FABP5抑制剂在焦虑和抑郁治疗方面显示出前景
Artelo’s FABP5 inhibitor shows promise for anxiety and depression
Artelo Biosciences任命Mark Spring为新任首席财务官
Artelo Biosciences appoints Mark Spring as new CFO
Artelo Biosciences任命Mark Spring为首席财务官并修订高管协议